Clinical trial

Clinical Laboratory Evaluation of Chronic Autonomic Failure

NCT03648905

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2018-09-06

PhaseN/A

Study timeline

Study start (actual)2018-09-06Date precision: day

Registry last updated2026-09-28

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Parkinson's Diseaseunresolved

Multiple System Atrophyunresolved

Autonomic Failureunresolved

Interventions

13N-AmmoniaDRUG

11C-Methylreboxetine (11C-MRB)DRUG

18F-DopamineDRUG

Sponsors & collaborators

National Institute of Neurological Disorders and Stroke (NINDS)lead sponsor

Mapped research locations

BethesdaMaryland, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03648905 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.